Research output per year
Research output per year
Personal profile
Education/Academic qualification
Master, Biotechnology and Bioengineering
1 Sept 2017 → 23 Nov 2018
Award Date: 23 Nov 2018
Bachelor, Biological Science , West Normal University
1 Sept 2013 → 16 Jun 2017
Award Date: 16 Jun 2017
Keywords
- QH301 Biology
- Bioengineering
- Protein-Protein Interactions
- CADD
Person Types
- Students
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Yuanyuan Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
IFN-β blocks the thymidine salvage pathway in Staphylococcus aureus through high-affinity binding to thymidine kinase
Ashraf, A., Aiman, A., Wang, Y., Khan, M. A., Khan, F. I., khan, L. A., Islam, A. & Hassan, M. I., 23 Jan 2026, In: International Journal of Biological Macromolecules. 344, 150508.Research output: Contribution to journal › Article › peer-review
Open Access -
Structural and functional insights into an anticancer peptide candidate derived from the EP400NL C-terminal domain
Liang, Y., Wang, Y., Sam, S., Li, Z., Khan, F. I. & Park, J. H., 9 Jul 2026, In: Biochemical and Biophysical Research Communications. 821, 153880.Research output: Contribution to journal › Article › peer-review
-
The FATP2 axis in cancer: Structural informatics and implications for drug discovery
Wang, Y., Zhang, Y., Zhang, B. & Khan, F. I., 22 Apr 2026, In: Drug Discovery Today. 31, 3, 104680.Research output: Contribution to journal › Review article › peer-review
-
Hepatitis B virus X protein contributes to hepatocellular carcinoma via upregulation of KIAA1429 methyltransferase and mRNA m6A hypermethylation of HSPG2/Perlecan.
Sivasudhan, E., Zhou, J., Ma, J., Wang, Y., Liu, S., Khan, F. I., Lu, Z., Meng, J., Blake, N. & Rong, R., Jan 2025, In: Molecular Carcinogenesis. 64, 1, p. 108-125 18 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Highly Potent Phosphinic HIV‑1 Protease Inhibitors: Synthesis, In Vitro Evaluation, and Docking Studies
Hayat, K., Qiu, D., Wang, Y., Imbenzi, P. S., Khan, F. I. & Matziari, M., 10 Dec 2025, In: ACS Omega.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus)
Activities
- 2 Presentation at conference/workshop/seminar
-
Structural Dynamics and Binding Mechanisms of Selected Inhibitors Targeting SARS-CoV-2 Main Protease
Wang, Y. (Speaker)
5 Mar 2025Activity: Talk or presentation › Presentation at conference/workshop/seminar
-
In Silico Studies of Potential Therapeutics for SARS-CoV-2: Drug Screening, Mechanisms of Action, and Implications for Therapeutic Application
Wang, Y. (Speaker)
24 May 2024 → 26 May 2024Activity: Talk or presentation › Presentation at conference/workshop/seminar